Tracing the alterations/modification of proinflammatory biomarkers including IL-1β, IL-6, IL-10, TNF-α, and RANTES in CSF or blood can be helpful in the early diagnosis, PD pathogenesis, and monitoring of disease progression. This evidence concerns the gene CCL5 and Parkinson disease.